Fundraising Fox
/People
Sign in

Kasper Roet

Founder

Founder, Chief Executive Officer at Quralis

Greater Boston

FoundedQuralis

Find your path to Kasper

Sign up to see every warm intro you have to Kasper

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Kasper. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Kasper Roet is the founder and CEO of QurAlis, a company focused on developing therapies for Amyotrophic Lateral Sclerosis (ALS). The company uses patient-derived stem cell technologies to study disease mechanisms in motor neurons and applies a precision medicine approach to identify potential treatments.

Founder, Chief Executive Officer at Quralis

Intro paths

→

In turn, Kasper can intro founders to Quralis's investors below.

Quralis's investors · 16

ALS Investment FundAmsterdam · since 2023Amgen VenturesThousand Oaks · $1M – $3M checks · since 2023Dementia Discovery FundLondon · since 2023Diamond Edge VenturesSan Francisco · since 2018Dolby Family VenturesSan Francisco · since 2023Droia VenturesLuxembourg · $540K checks · since 2025EQT Life SciencesAmsterdam · $11M – $66M checks · since 2023InkefAmsterdam · since 2023MC Healthcare VenturesCambridgeMission Bay CapitalSan Francisco · since 2023Mission BiocapitalSan Francisco · $500K checks · since 2025Mitsui Global InvestmentMenlo Park · $500K – $10M checks · since 2023Polaris PartnersBoston · $500K – $5M checks · since 2025Sanofi VenturesCambridge · $5M checks · since 2023SV Health InvestorsLondon · $1M – $20M checksSynconaLondon · since 2022

Co-founders at Quralis

KEKevin Eggan
Kevin EgganFounder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical
R
RoetCo-founder
W
WoolfCo-founder
CW
Clifford WoolfFounder, QurAlis; Director, Boston Children's Hospital and Harvard Stem Cell Institute

Frequently asked questions

Who is Kasper Roet?
Kasper Roet is the founder and CEO of QurAlis, a company focused on developing therapies for Amyotrophic Lateral Sclerosis (ALS). The company uses patient-derived stem cell technologies to study disease mechanisms in motor neurons and applies a precision medicine approach to identify potential treatments.
Where does Kasper Roet work?
Kasper Roet is Founder, Chief Executive Officer of Quralis.
What companies did Kasper Roet found?
Kasper Roet founded Quralis.

Founder mafias

About this profile. Compiled from public sources — Quralis's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights